India helps pharmas compete for WHO contracts

The Indian government is planning a subsidy scheme for mid-size drugmakers to bring their facilities in line with WHO manufacturing standards. Most already comply with the standards of the country's Drugs and Cosmetics Act, so officials believe that the facility upgrades will be of limited scope. A proposal now in the works provides an interest subsidy to the qualifying companies. Article

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.